ArborMetrix is a technology company.
ArborMetrix has raised $7.0M across 1 funding round.
ArborMetrix has raised $7.0M in total across 1 funding round.
ArborMetrix has raised $7.0M in total across 1 funding round.
ArborMetrix's investors include Grand Ventures.
ArborMetrix is a healthcare technology company that builds analytics software platforms to transform real-world healthcare data into actionable insights, measuring the effectiveness of treatments, procedures, medical devices, and pharmaceuticals.[1][2][3] It serves hospitals, health systems, medical specialty societies, hospital associations, payers, and providers, solving problems like optimizing clinical and financial performance, reducing care variation, enabling value-based care, and driving quality improvements amid evolving payment models.[2][3][4][6] The platform supports predictive analytics, real-time interventions, mandatory reporting like MIPS, and episode-of-care management, with demonstrated growth including partnerships like Sound Physicians for BPCI-A programs and funding under $5 million across three rounds.[3][5][6]
Founded in 2011 and headquartered in Ann Arbor, Michigan, ArborMetrix emerged from expertise in data science, technology, informatics, and healthcare to address the need for evidence-based insights in a shifting care delivery landscape.[1][2][3] Specific founders are not detailed in available sources, but the company quickly gained traction through collaborations like the Michigan Bariatric Surgery Collaborative (MBSC), powered by its platform to deliver outcomes calculators, patient-reported outcomes, and surgical analysis—resulting in a 67% post-surgical mortality reduction and $35 million in statewide savings.[7] Early focus on provider performance analytics evolved into broader value-based care solutions, with milestones including a 2017 partnership with Sound Physicians for standardized business intelligence.[3][6]
ArborMetrix rides the wave of value-based care and real-world evidence (RWE) trends, where payers and providers shift from fee-for-service to outcome-linked payments amid rising healthcare costs and data interoperability demands.[2][4][6] Timing aligns with mandates like MIPS and BPCI-A, plus post-pandemic emphasis on analytics for efficiency and population health; market forces like Blue Cross Blue Shield funding for collaboratives amplify its impact.[3][6][7] It influences the ecosystem by enabling quality collaboratives (e.g., MBSC's statewide savings), clinician engagement via timely data, and research acceleration, competing with peers like Verato and Redox in healthcare data unification while standing out in provider-focused performance metrics.[1][7]
ArborMetrix is poised to expand as AI-enhanced predictive tools and RWE gain traction in personalized medicine and bundled payments, potentially scaling partnerships with large hospitalist groups and payers for broader adoption.[4][6] Trends like FHIR interoperability and regulatory pushes for outcomes data will shape its growth, evolving its influence from niche analytics to integral ecosystem enabler—building on proven wins like MBSC to deliver more lives saved and cost efficiencies.[2][7] This positions it as a key player in data-driven healthcare transformation, directly advancing its founding mission.
ArborMetrix has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series B in March 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2016 | $7.0M Series B | Grand Ventures |